Evigrade
Moderate

Amitriptyline × Warfarin

Tricyclic antidepressants (TCA)×Vitamin K antagonist anticoagulants

Mechanism

Amitriptyline is metabolised via CYP2C9 (a minor route) – weak competition with warfarin is possible. Mild INR rises have been reported when adding a TCA.

Symptoms

Mostly no changes. In some patients: a 10–15% INR rise 2–4 weeks after starting amitriptyline.

Management

After starting amitriptyline, check INR at 2 and 4 weeks, then resume routine monitoring. If INR rises above target, reduce warfarin by 5–10%. Alternative antidepressants without CYP2C9 dependence: sertraline or agomelatine.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions